Back

Clinical characteristics and outcomes of aortic stenosis patients with and without standard modifiable cardiovascular risk factors

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Aortic stenosis: current epidemiology and progression Aortic Valve Stenosis ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Ms Elizabeth Grace Hui En Thong

National University Heart Centre, Singapore (Singapore)

8 More presentations in this session

Presentation thumbnail
Temporal trends in the incidence and mortality of calcified arotic valve disease in the nordic countries over the past 30 years
Doctor Z. Abdulelah (Cambridge, GB)
Abstract Slides Video
Presentation thumbnail
Current trends in aortic stenosis presentation, progression and treatment a retrospective cohort study
Doctor M. Ohad (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
Changes in demographics, strategies, and clinical outcomes of severe aortic stenosis in the pre- and post-TAVR Era
Doctor Y. Obayashi (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
The presentation and progression of bicuspid aortic valve disease in the modern era
Doctor M. Ohad (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
Aortic valve tissue characteristics and aortic stenosis in patients with bicuspid aortic valve
Doctor A. Guala (Barcelona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Aortic stenosis: current epidemiology and progression

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Acute coronary syndromes without the usual suspects: prevalence and clinical outcomes of patients without standard modifiable risk factors (SMuRF-less)
thumbnail
Congress Presentation
Clinical outcomes of patients undergoing percutaneous coronary intervention for coronary artery disease without standard modifiable cardiovascular risk factors according to clinical presentation
thumbnail
Congress Session
Improving prognosis after TAVI

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources